1 / 2

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Clinical profiles and outcomes of patients with chronic heart failure and chronic obstructive pulmonary disease: efficacy and safety of ivabradine . A SHIFT study analysis.

brac
Download Presentation

S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Systolic Heart failure treatment withthe Ifinhibitor ivabradineTrial Clinical profiles and outcomes of patients with chronic heart failure and chronic obstructive pulmonary disease: efficacy and safety of ivabradine. A SHIFT study analysis TavazziL, et al. Int J Cardiol. 2013. Dec 10;170(2):182-188 www.shift-study.com

  2. 50 45 40 COPD (placebo) COPD (ivabradine) 35 30 Non-COPD (placebo) Patients (%) 25 Non-COPD (ivabradine) 20 15 10 5 0 0 6 12 18 24 Time (months) Effect of ivabradine on composite of CV death or HF hospitalization Ivabradine is safe and effective in lowering the relative risk of the primary composite end point in both COPD and non-COPD patients www.shift-study.com Tavazzi L et al. Int J Cardiol. 2013. Dec 10;170(2):182-188

More Related